OBJECTIVE: This study investigated whether medically significant obesity (body mass index > 30 kg=m 2 ) is recognised effectively in hospital outpatient departments and how those identified as obese are subsequently managed. DESIGN: A retrospective analysis of patients' hospital records (rheumatology n ¼ 108, cardiology n ¼ 257, orthopaedic n ¼ 250) established the reported prevalence of obesity and subsequent referral patterns. In addition, BMI was measured prospectively on a separate cohort (rheumatology n ¼ 188, cardiology n ¼ 203, orthopaedic n ¼ 179) to determine the true prevalence. RESULTS: Generally, obesity management appeared minimal and inconsistent. Retrospective analysis revealed an apparently low rate of obesity (4% cardiology, 5% rheumatology and 3% orthopaedics), whilst the true prevalence was found to be 30% for cardiology, 25.1% for orthopaedics and 20.2% for rheumatology. Although this appears to show a large disparity between the apparent and the true prevalence, it is impossible to establish precisely the degree of under-estimation, as the lack of height measurements (14% only) in the retrospective sample affects the reliability of the apparent prevalence. Further comparison with the general population showed obesity to be particularly common in men attending cardiology clinics. CONCLUSION: An outpatient clinic consultation could be a useful starting point for integrating obesity and disease management, by helping to identify obesity, initiate appropriate referrals and assist in obesity education.
Introduction
The prevalence of obesity is increasing globally and 20% of the UK population are currently obese (body mass index (BMI) > 30 kg=m 2 ). 1 Moreover, if the level of obesity continues to rise at its current rate, one-third of all adults are likely to have clinically significant obesity by the year 2010. 2 Obesity adversely influences morbidity and mortality and is placing an ever-increasing burden on Western health budgets, with obesity costing the National Health Service at least £0.5 billion in 1998. 3, 4 The 'big three' cost drivers of hypertension, coronary heart disease and type 2 diabetes accounted for £386 million, with osteoarthritis and stroke accounting for a further £52 million. 4 It is clearly imperative that obesity is targeted as an area for immediate action and priority is given to identifying and treating obesity in individuals with obesity-related diseases, especially as even a modest weight loss of 5 -10% can produce clinically beneficial improvements in all modifiable risk factors, such as blood glucose, blood pressure and lipids. 5, 6 Hospital outpatient departments see many patients with obesity-related co-morbidities and are an obvious starting point to begin this process. However, there is a suspicion that, for some patients attending outpatient departments, the presenting medical problem receives attention, but the underlying obesity is often ignored and untreated. This study investigated whether medically significant obesity is recognised effectively in such departments and how those identified as obese are subsequently managed.
Subjects, methods and results
We first determined the reported prevalence of obesity and the action taken in cardiology, rheumatology and orthopaedic outpatients clinics at University Hospital Aintree. Cardiology and orthopaedic clinics were chosen because ischaemic heart disease and osteoarthritis are two important co-morbidities of obesity, while a general rheumatology clinic probably reflects the obesity levels in the general population.
BMI is accepted as the most appropriate index with which to define differing levels of overweight and obesity, as a strong correlation exists between BMI and the percentage of fat in large populations. 7 Normal BMI is defined as 18.5 -24.9 kg=m 2 , overweight as 25.0 -29.9 kg=m 2 and above as obese. 8 Thus hospital records of clinic attendees were examined retrospectively (rheumatology n ¼ 108, cardiology n ¼ 257, orthopaedic n ¼ 250) for records of weight and height and any resulting calculations of BMI.
Body weight was recorded in 67% of cardiology, 17% of orthopaedic and 31.5% of rheumatology patients. However, height was measured so infrequently (14% in all cases) that only modest rates of obesity ranging from 3 to 5% could be identified, suggesting that obesity prevalence is not recorded reliably. Height measurements, when taken, were usually at the initial visit and were requested by some consultants but not others (Table 1) . Further action taken was categorised as: discussion with clinician; referral to a dietician; referral to GP; referral to other specialist service;
and varied from only 3.6% in orthopaedic clinics to 17.5% in cardiology and 21.3% in rheumatology (Table 1) . Most cardiology referrals were to the cardiac rehabilitation programme, where patients are offered one group session with a dietician only after they have experienced a significant cardiac event. Although one rheumatologist in particular frequently discussed weight with patients, only 4.1% in total were referred to a dietician.
A prospective study was then performed to determine the true prevalence of obesity within these clinics. Weight, height and waist circumference were measured in a separate cohort of 570 patients, as practical difficulties prevented measurement of the retrospective study cohort. The portable Raven Minimeter height measure and portable Seca Scales were used to perform all measurements, as some clinics did not have access to a height measure and weights were found to vary by as much as 3 kg between different clinics' scales. Outer garments and shoes were removed and those who were non-weight bearing or with malignancy were excluded. Two patients refused consent.
Some 20.2% of rheumatology, 25.1% of orthopaedic and 30% of cardiology patients were identified as obese. Although this appears to show a large disparity between the apparent and the true prevalence, it is impossible to establish precisely the degree of under-estimation, due to the unreliability of the apparent prevalence. The true clinic prevalence of obesity and waist circumference distribution was compared to the general population of England using the normal approximation to the binomial distribution. 1, 9 Subjects aged under 35 were excluded to ensure age range comparability (Table 2) . Obesity was particularly common in men attending cardiology clinics, although the orthopaedic clinic figures approached significance. The high waist circumference in those attending cardiology clinics is of particular significance as waist circumference of > 102 cm (males) and > 88 cm (females) is an indicator of an android or truncal distribution of fat around the abdomen and viscera which is commonly associated with cardio-vascular disease. 10, 11 Although 51% of patients were over this threshold; only 17.5% had any action taken ( Table 2 ).
Discussion
It is apparent that although obesity is common in outpatient clinics, opportunities for diagnosis and treatment appear to be missed, despite the importance of doing so with a disease recognized as a diagnosis under the International Classification of Diseases (ICD). One possible explanation may be a lack of awareness amongst clinicians of the impact of obesity on disease progression and severity, however the growing body of advisory statements on obesity and treatment protocols, makes this unlikely. 12, 13 It is more probable that clinicians may not have the skills or time to address this complex heterogeneous problem effectively in the short consultation time available in the out-patient setting. Indeed, clinically meaningful weight loss is best achieved with a combined approach comprising medical assessment, individualised dietary advice, exercise and behavioural programmes, with some patients requiring the added support of drug treatment and surgery. 14 The current paucity of such services to support weight management discourages referral. Ironically, the only way to reverse this effect and achieve an increase in resources for a specialist service is to provide evidence of increased demand and this would only be achieved through identification of the prevalence of obesity and increasing referral rates. Clinic protocols can be easily adapted to gather evidence of obesity, and guide clinicians towards more appropriate referrals, with both BMI and waist circumference as appropriate measurements. Indeed the latter may be the tool of choice, being quicker to measure and not requiring a calculation. 8, 11 Thus, an outpatient clinic consultation for an obesityrelated problem is a useful starting point for integrating obesity and disease management, both by helping to identify obesity and initiate appropriate referrals. Although measurement alone does not alter practice, at the very least, it is an Obesity in outpatient departments J Cleator et al (n ¼ sample size) Obesity in outpatient departments J Cleator et al ideal opportunity to raise awareness of obesity among clinic populations, especially when the disease is obesity-related and to deliver the crucial message that modest degrees of weight loss are both desirable and achievable in disease management. 5 
